Intelgenx Technologies Corp (IGXT)
0.1619
-0.02
(-9.30%)
USD |
OTCM |
May 03, 16:00
Intelgenx Technologies Market Cap: 28.28M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 28.28M |
| May 02, 2024 | 31.18M |
| May 01, 2024 | 31.44M |
| April 30, 2024 | 28.32M |
| April 29, 2024 | 27.95M |
| April 26, 2024 | 28.64M |
| April 25, 2024 | 29.10M |
| April 24, 2024 | 26.20M |
| April 23, 2024 | 28.63M |
| April 22, 2024 | 29.67M |
| April 19, 2024 | 28.82M |
| April 18, 2024 | 29.69M |
| April 17, 2024 | 27.95M |
| April 16, 2024 | 31.44M |
| April 15, 2024 | 29.69M |
| April 12, 2024 | 32.33M |
| April 11, 2024 | 31.50M |
| April 10, 2024 | 32.66M |
| April 09, 2024 | 31.48M |
| April 08, 2024 | 30.39M |
| April 05, 2024 | 29.52M |
| April 04, 2024 | 32.31M |
| April 03, 2024 | 30.57M |
| April 02, 2024 | 29.34M |
| April 01, 2024 | 30.13M |
| Date | Value |
|---|---|
| March 28, 2024 | 30.74M |
| March 27, 2024 | 32.14M |
| March 26, 2024 | 30.04M |
| March 25, 2024 | 29.44M |
| March 22, 2024 | 27.95M |
| March 21, 2024 | 28.42M |
| March 20, 2024 | 27.18M |
| March 19, 2024 | 28.68M |
| March 18, 2024 | 29.69M |
| March 15, 2024 | 28.87M |
| March 14, 2024 | 28.87M |
| March 13, 2024 | 28.21M |
| March 12, 2024 | 28.86M |
| March 11, 2024 | 29.00M |
| March 08, 2024 | 30.91M |
| March 07, 2024 | 27.21M |
| March 06, 2024 | 27.89M |
| March 05, 2024 | 27.64M |
| March 04, 2024 | 29.69M |
| March 01, 2024 | 27.42M |
| February 29, 2024 | 27.67M |
| February 28, 2024 | 27.42M |
| February 27, 2024 | 25.82M |
| February 26, 2024 | 25.36M |
| February 23, 2024 | 25.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
14.00M
Minimum
Mar 27 2020
93.14M
Maximum
Jun 17 2021
38.66M
Average
33.67M
Median
Jan 30 2020
Market Cap Benchmarks
| Acasti Pharma Inc | 27.82M |
| Aurinia Pharmaceuticals Inc | 729.40M |
| Edesa Biotech Inc | 14.69M |
| Lexaria Bioscience Corp | 40.33M |
| Xenon Pharmaceuticals Inc | 3.302B |
Market Cap Related Metrics
| PS Ratio | 27.22 |
| Price | 0.1619 |
| Earnings Yield | -37.06% |